Pharmhouse Corp Cash Flow-to-Debt Ratio
Pharmhouse Corp cash flow-to-debt ratio. Pharmhouse Corp (PHSE) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2026, meaning its operating cash flow of $362.87K could theoretically repay 0% of its total liabilities ($7.42 Million) in one year. Check Pharmhouse Corp cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pharmhouse Corp (1996–2025)
Cash flow-to-debt ratio of Pharmhouse Corp from 1996 to 2025. Historical debt coverage capacity for Pharmhouse Corp across 9 annual periods. Check PHSE cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Pharmhouse Corp Cash Flow-to-Debt Ratio by Year (1996–2025)
Pharmhouse Corp cash flow-to-debt ratio by year from 1996 to 2025. Year-by-year debt coverage analysis for Pharmhouse Corp. For the full cash flow conversion analysis, see Pharmhouse Corp cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.31x | $-2.49 Million | $8.05 Million | ▲ +13.5% |
| 2024 | -0.36x | $-614.75K | $1.72 Million | ▼ -107.5% |
| 2023 | 4.76x | $1.71 Million | $358.92K | ▲ +960.5% |
| 2021 | -0.55x | $-71.12K | $128.47K | ▲ +92.3% |
| 2020 | -7.20x | $-1.95 Million | $271.45K | ▼ -43170.9% |
| 2019 | 0.02x | $652.00 | $39.00K | ▲ +102.5% |
| 1998 | -0.67x | $-1.93 Million | $2.88 Million | ▼ -88.1% |
| 1997 | -0.36x | $-1.83 Million | $5.13 Million | ▲ +20.7% |
| 1996 | -0.45x | $-2.44 Million | $5.43 Million | — |